IBio, Income Quality from 2010 to 2025
| IBIO Stock | USD 4.63 0.07 1.54% |
Income Quality | First Reported 2010-12-31 | Previous Quarter 0.67 | Current Value 0.62 | Quarterly Volatility 0.21247982 |
Check IBio, Common financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among IBio, Common's main balance sheet or income statement drivers, such as Depreciation And Amortization of 1.2 M, Interest Expense of 187.9 K or Total Revenue of 245.8 K, as well as many indicators such as Price To Sales Ratio of 37.39, Dividend Yield of 0.033 or PTB Ratio of 0.39. IBio, financial statements analysis is a perfect complement when working with IBio, Common Valuation or Volatility modules.
IBio, | Income Quality |
Latest IBio, Common's Income Quality Growth Pattern
Below is the plot of the Income Quality of iBio, Common Stock over the last few years. It is an assessment of the sustainability of a company's earnings over time, considering factors like revenue source diversification and cost structure. IBio, Common's Income Quality historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in IBio, Common's overall financial position and show how it may be relating to other accounts over time.
| Income Quality | 10 Years Trend |
|
Income Quality |
| Timeline |
IBio, Income Quality Regression Statistics
| Arithmetic Mean | 0.80 | |
| Geometric Mean | 0.77 | |
| Coefficient Of Variation | 26.67 | |
| Mean Deviation | 0.15 | |
| Median | 0.78 | |
| Standard Deviation | 0.21 | |
| Sample Variance | 0.05 | |
| Range | 0.827 | |
| R-Value | (0.23) | |
| Mean Square Error | 0.05 | |
| R-Squared | 0.05 | |
| Significance | 0.40 | |
| Slope | (0.01) | |
| Total Sum of Squares | 0.68 |
IBio, Income Quality History
About IBio, Common Financial Statements
IBio, Common investors utilize fundamental indicators, such as Income Quality, to predict how IBio, Stock might perform in the future. Analyzing these trends over time helps investors make informed market timing decisions. For further insights, please visit our fundamental analysis page.
| Last Reported | Projected for Next Year | ||
| Income Quality | 0.67 | 0.62 |
Pair Trading with IBio, Common
One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if IBio, Common position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in IBio, Common will appreciate offsetting losses from the drop in the long position's value.Moving against IBio, Stock
| 0.81 | SCLX | Scilex Holding | PairCorr |
| 0.81 | ASMB | Assembly Biosciences Earnings Call This Week | PairCorr |
| 0.79 | CDIOW | Cardio Diagnostics | PairCorr |
| 0.73 | CMND | Clearmind Medicine Common | PairCorr |
| 0.71 | ELVN | Enliven Therapeutics | PairCorr |
The ability to find closely correlated positions to IBio, Common could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace IBio, Common when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back IBio, Common - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling iBio, Common Stock to buy it.
The correlation of IBio, Common is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as IBio, Common moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if iBio, Common Stock moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for IBio, Common can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.Check out the analysis of IBio, Common Correlation against competitors. You can also try the Earnings Calls module to check upcoming earnings announcements updated hourly across public exchanges.
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of IBio, Common. If investors know IBio, will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about IBio, Common listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (4.03) | Revenue Per Share | Quarterly Revenue Growth (0.88) | Return On Assets | Return On Equity |
The market value of iBio, Common Stock is measured differently than its book value, which is the value of IBio, that is recorded on the company's balance sheet. Investors also form their own opinion of IBio, Common's value that differs from its market value or its book value, called intrinsic value, which is IBio, Common's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because IBio, Common's market value can be influenced by many factors that don't directly affect IBio, Common's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between IBio, Common's value and its price as these two are different measures arrived at by different means. Investors typically determine if IBio, Common is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, IBio, Common's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.